Skip to content

In the BioHarmony Drug Report Database

Cerliponase alfa

Brineura (cerliponase alfa) is an enzyme pharmaceutical. Cerliponase alfa was first approved as Brineura on 2017-04-27. It is used to treat neuronal ceroid-lipofuscinoses in the USA. It has been approved in Europe to treat neuronal ceroid-lipofuscinoses.
Trade Name Brineura
Common Name Cerliponase alfa
Indication neuronal ceroid-lipofuscinoses
Drug Class Enzymes
Cerliponase alfa
Get full access now